Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9217 |
High Similarity |
NPD8053 |
Approved |
0.9217 |
High Similarity |
NPD8054 |
Approved |
0.8795 |
High Similarity |
NPD8252 |
Approved |
0.8795 |
High Similarity |
NPD8099 |
Discontinued |
0.8795 |
High Similarity |
NPD8251 |
Approved |
0.8743 |
High Similarity |
NPD8156 |
Discontinued |
0.8544 |
High Similarity |
NPD4584 |
Approved |
0.8516 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD2560 |
Approved |
0.8415 |
Intermediate Similarity |
NPD2563 |
Approved |
0.8364 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8235 |
Intermediate Similarity |
NPD27 |
Approved |
0.8235 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8232 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8199 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.8192 |
Intermediate Similarity |
NPD7906 |
Approved |
0.8176 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8176 |
Intermediate Similarity |
NPD2970 |
Approved |
0.8118 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8118 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.8068 |
Intermediate Similarity |
NPD4578 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7310 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7313 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7312 |
Approved |
0.8068 |
Intermediate Similarity |
NPD4577 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7311 |
Approved |
0.8034 |
Intermediate Similarity |
NPD4663 |
Approved |
0.8023 |
Intermediate Similarity |
NPD7309 |
Approved |
0.8023 |
Intermediate Similarity |
NPD2898 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7975 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7844 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7751 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7709 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7665 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7665 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7665 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD1613 |
Approved |
0.761 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7609 |
Intermediate Similarity |
NPD2490 |
Approved |
0.758 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7579 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7579 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7578 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7547 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.753 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5773 |
Approved |
0.75 |
Intermediate Similarity |
NPD4582 |
Approved |
0.75 |
Intermediate Similarity |
NPD4585 |
Approved |
0.75 |
Intermediate Similarity |
NPD4583 |
Approved |
0.75 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7455 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7448 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7448 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7443 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7439 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7399 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7399 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.73 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.7294 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7288 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7247 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7228 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7213 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7466 |
Approved |
0.72 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7198 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7198 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7176 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD5242 |
Approved |
0.716 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3808 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD2155 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2156 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD3365 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7062
|
Intermediate Similarity |
NPD5977 |
Approved |